| Women's perspectives on counseling about risks for medication-induced birth defects. | |
| | |
MedLine Citation:
|
PMID: 19637252 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
PURPOSE: This qualitative study explored women's experiences with counseling about medication-induced birth defects, as well as how and when they would like to receive information on medication-induced birth defects from their health care providers (HCPs). METHODS: We conducted four focus groups with 36 women of reproductive age (18-45 years old) in Pittsburgh, Pennsylvania. Twenty-one women were using medications to treat a chronic health condition, and two were pregnant. Content analysis was performed by three independent coders using a grounded theory approach. Discrepancies were resolved by consensus. RESULTS: Women reported depending on their HCPs for information about the risks of teratogenic effects of medications on a pregnancy, but felt the information they had been provided was not always comprehensive. Women want HCPs to initiate discussions about potentially teratogenic medications at the time the medications are prescribed, regardless of whether the woman is sexually active or planning a pregnancy. Women want clear information about all potential outcomes for a fetus. Factors women reported as being critical to effective teratogenic risk counseling included privacy, sufficient time to discuss the topic, and a trusting relationship with their HCP. CONCLUSIONS: Women of reproductive age think that providing information about the possible teratogenic effects of medications could be improved by routine discussions of teratogenic risks at the time medications are prescribed. |
| | |
Authors:
|
Aimee K Santucci; Melanie A Gold; Aletha Y Akers; Sonya Borrero; Eleanor Bimla Schwarz |
Publication Detail:
|
Type: Journal Article; Research Support, U.S. Gov't, P.H.S. |
Journal Detail:
|
Title: Birth defects research. Part A, Clinical and molecular teratology Volume: 88 ISSN: 1542-0760 ISO Abbreviation: Birth Defects Res. Part A Clin. Mol. Teratol. Publication Date: 2010 Jan |
Date Detail:
|
Created Date: 2010-01-13 Completed Date: 2010-03-16 Revised Date: 2011-09-26 |
Medline Journal Info:
|
Nlm Unique ID: 101155107 Medline TA: Birth Defects Res A Clin Mol Teratol Country: United States |
Other Details:
|
Languages: eng Pagination: 64-9 Citation Subset: IM |
Copyright Information:
|
Copyright 2009 Wiley-Liss, Inc. |
Affiliation:
|
Center for Research on Health Care, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Abnormalities, Drug-Induced* Adolescent Adult Counseling* Female Focus Groups / methods Health Knowledge, Attitudes, Practice* Health Personnel Humans Middle Aged Pharmaceutical Preparations / adverse effects* Preconception Care Pregnancy Risk Assessment Teratogens / toxicity* Women's Health* Young Adult |
| Grant Support | |
ID/Acronym/Agency:
|
K23 HD051585-04/HD/NICHD NIH HHS; R18 HS017093-01/HS/AHRQ HHS |
| Chemical | |
Reg. No./Substance:
|
0/Pharmaceutical Preparations; 0/Teratogens |
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: From large analogical instruments to small digital black boxes: 40 years of progress in mass spectro...
Next Document: Genetic skeletal disorders of the fetus and infant: pathologic and molecular findings in a series of...